IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo Tania BenatarMing Y. CaoAiping H. Young Original Article 13 December 2009 Pages: 805 - 817
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment Thaís Helena GasparotoTatiana Salles de Souza MalaspinaAna Paula Campanelli Original Article 12 December 2009 Pages: 819 - 828
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked Marie von Lilienfeld-ToalSusanne FrankGordon Cook Original Article 19 December 2009 Pages: 829 - 839
Circulating tumour-derived microvesicles in plasma of gastric cancer patients Jaroslaw BaranMonika Baj-KrzyworzekaMarek Zembala Original Article 31 December 2009 Pages: 841 - 850
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting Håkan NorellYi ZhangMichael I. Nishimura Original Article 06 January 2010 Pages: 851 - 862
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine Adam DangoorPaul LoriganRobert Hawkins Original Article 31 December 2009 Pages: 863 - 873
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity Norimasa MatsushitaHiroshi KomineJames J. Mulé Original Article 08 January 2010 Pages: 875 - 884
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity Hong LinElisa de StanchinaSusanna Cunningham-Rundles Original Article 06 February 2010 Pages: 885 - 897
Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice Bohan DongLuguo SunLiying Wang Original Article 20 January 2010 Pages: 899 - 908
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma Martin PölcherMichael BraunJuan-José Hernando Original Article 20 January 2010 Pages: 909 - 919
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells Nadine PouwElike Treffers-WesterlakenReno Debets Original Article 26 January 2010 Pages: 921 - 931
Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro Yinting ChenKaihong HuangYing Wu Original Article 12 March 2010 Pages: 933 - 942
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase Brian M. OlsonThomas P. FryeDouglas G. McNeel Original Article 06 February 2010 Pages: 943 - 953
“Tumor immunology meets oncology IV”, 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany Juergen BukurDennis LoefflerBarbara Seliger Meeting Report 28 August 2008 Pages: 955 - 962
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008 Michele MaioHugues J. M. Nicolayfor the NIBIT Meeting Report 28 March 2009 Pages: 963 - 969
The second cellular therapy of cancer symposium, 27–29 March 2009, Milan, Italy John S. BridgemanDavid E. GilhamEleanor J. Cheadle Meeting Report 08 August 2009 Pages: 971 - 974